![](/img/cover-not-exists.png)
Cost-Effectiveness Analysis Of Panitumumab + Folfox Compared To Cetuximab + Folfiri As First-Line Treatment For Patients With Wild-Type (Wt) Ras (Exons 2, 3, And 4 Of Kras And Nras) Metastatic Colorectal Cancer (Mcrc) In Colombia
Vargas-Valencia, J, Garcia Perlaza, JVolume:
18
Language:
english
Journal:
Value in Health
DOI:
10.1016/j.jval.2015.09.1188
Date:
November, 2015
File:
PDF, 52 KB
english, 2015